← Open Payments lookup

COLLETTE OMOROGBE: Open Payments

NPI 1922882232 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,451 in 62 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $708 · 2025 $1,451

Food & beverage: $1,340Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.6$225
ABBVIE INC.10$205
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$204
E.R. Squibb & Sons, L.L.C.4$139
Lundbeck LLC7$131
Neurocrine BioSciences, Inc.4$112
Vanda Pharmaceuticals Inc.4$111
Collegium Pharmaceutical, Inc.4$102
Otsuka America Pharmaceutical, Inc.4$96
Alkermes, Inc.2$64

Products named: VRAYLAR, CAPLYTA, COBENFY, ABILIFY MAINTENA, INGREZZA, HETLIOZ, Jornay PM, REXULTI.

Industry payments across MD — which companies pay providers there.